SKI Market

Indian Indices

Sensex

82,276.07 50.15
( 0.06%)

Global Indices

Nasdaq

49,202.49 377.42
(0.77%)

Dow Jones

6,910.52 51.77
(0.75%)

Hang Seng

58,650.11 1,329.02
(2.32%)

Nikkei 225

10,802.86 122.27
(1.14%)

Forex

USD-INR

90.87 0.15
(0.16%)

EUR-INR

107.26 0.37
(0.35%)

GBP-INR

122.73 0.47
(0.39%)

JPY-INR

0.59 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5552288

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.38

107135.95

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.21

Back

Rallis India appoints director

Dec 08,2025

Rallis India has appointed Mahesh Girdhar (DIN: 10270848) as an Additional Director in Independent capacity, for an initial term of 5 (five) years commencing from 10 December 2025 up to 09 December 2030 (both days inclusive), subject to approval of the shareholders.

82,276.07 50.15 ( 0.06%)

49,202.49 377.42 (0.77%)

6,910.52 51.77 (0.75%)

58,650.11 1,329.02 (2.32%)

10,802.86 122.27 (1.14%)

90.87 0.15 (0.16%)

107.26 0.37 (0.35%)

122.73 0.47 (0.39%)

0.59 0.00 (0.51%)